Invention Grant
- Patent Title: Diacylglycerol acyl transferase 2 inhibitors
-
Application No.: US15674914Application Date: 2017-08-11
-
Publication No.: US10071992B2Publication Date: 2018-09-11
- Inventor: Markus Boehm , Shawn Cabral , Matthew S. Dowling , Kentaro Futatsugi , Kim Huard , Esther Cheng Yin Lee , Allyn T. Londregan , Jana Polivkova , David A. Price , Qifang Li
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent A. Dean Olson
- Main IPC: C07D401/00
- IPC: C07D401/00 ; C07D253/08 ; C07D401/04 ; A61K9/14 ; C07D405/14 ; A61K31/506 ; A61K45/06 ; C07D409/14 ; C07D401/14
Abstract:
Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
Public/Granted literature
- US20180051012A1 DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS Public/Granted day:2018-02-22
Information query
